SMTL ID : 5jog.1

CRYSTAL STRUCTURE OF CSN5(2-257) IN COMPLEX WITH CNS5i-3

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.46 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: H.138, H.140, D.151 Ligands: 6LT.2 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:H.138, A:H.140, A:D.151, A:D.151

1 x 6LT: 3-(difluoromethyl)-N-{6-[(5S,6S)-6-hydroxy-6,7,8,9-tetrahydro-5H-imidazo[1,5-a]azepin-5-yl][1,1'-biphenyl]-3-yl}-1-(propan-2-yl)-1H-pyrazole-5-carboxamide(Non-covalent)

6LT.2: 13 residues within 4Å: Chain A: E.76, V.77, M.78, W.136, H.138, H.140, Y.143, I.150, D.151, T.154, L.157, N.158 Ligands: ZN.1 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:E.76, A:E.76, A:M.78, A:W.136, A:W.136, A:T.154 Hydrogen bonds: A:T.154, A:T.154

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Schlierf, A. et al., Targeted inhibition of the COP9 signalosome for treatment of cancer. Nat Commun (2016)

Release Date

2016-11-02

Peptides

COP9 signalosome complex subunit 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

COP9 signalosome complex subunit 5

Related Entries With Identical Sequence